Healthcare Financial Resources, LLC

Healthcare Financial Resources, LLC is focused on enhancing revenue cycle management (RCM) through innovative healthcare analytics and technology-driven solutions that improve operational efficiency and financial performance for healthcare organizations. Founded in 1984, Healthcare Financial Resources, LLC specializes in revenue cycle management solutions. The company is headquartered in Elgin, US. In May 2022, it was acquired by CorroHealth, supporting an expansion of both companies' product offerings and customer base.

Jerry Connelly serves as the CEO. Healthcare Financial Resources, LLC provides a comprehensive suite of healthcare analytics and technology-driven solutions focused on revenue cycle management (RCM). Their services include Clinical Documentation Improvement (CDI), coding services, claims management, and utilization management, aimed at improving operational efficiency and financial health within healthcare organizations. The company utilizes proprietary technologies such as VISION Clinical Validation Technology™, PULSE Coding Automation Technology™, and REVIVE Specialized RCM Automation™.

Their primary clientele includes hospitals and health systems across various markets, including the US and the Gulf Cooperation Council (GCC) region. Healthcare Financial Resources, LLC generates revenue through a B2B model, primarily by offering subscription-based services related to revenue cycle management. Clients subscribe to various modules of their RCM platform, which includes flagship products such as PULSE Coding Automation Technology™ and VISION Clinical Validation Technology™. Their pricing structure is flexible, catering to healthcare organizations' operational needs.

Additional revenue streams are derived from outsourced coding, billing audits, and financial counseling services. Following its acquisition by CorroHealth in May 2022, Healthcare Financial Resources, LLC plans to leverage this partnership to expand its product offerings and customer base. The recent acquisition will facilitate entry into new markets, particularly aiming to enhance their presence in international territories by 2023. The strategic investment will focus on developing new product lines and enhancing existing technologies, further supporting their growth initiatives.